Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Principal Healthcare Innovators Index (BTEC)

Principal Healthcare Innovators Index (BTEC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Principal Financial Group
  • Assets Under Management 97,911,000
  • Market Capitalization, $K 97,911
  • Shares Outstanding, K 2,150
  • 60-Month Beta 1.42
  • Price/Earnings ttm 23.29
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Management Fee 0.42%
  • Sectors:

    ETFs - Large Cap

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.93 +16.11%
on 06/12/20
46.53 -0.36%
on 07/08/20
+3.44 (+8.01%)
since 06/08/20
3-Month
33.19 +39.68%
on 04/13/20
46.53 -0.36%
on 07/08/20
+13.66 (+41.78%)
since 04/08/20
52-Week
25.34 +82.96%
on 03/18/20
46.53 -0.36%
on 07/08/20
+12.85 (+38.36%)
since 07/08/19

Most Recent Stories

More News
Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up

Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.

AZN : 54.19 (+1.35%)
MRNA : 61.58 (+0.80%)
GSK : 40.73 (+0.87%)
NVAX : 98.30 (-5.99%)
CNCR : 27.76 (+0.54%)
INO : 23.46 (-2.62%)
PTH : 129.29 (+1.28%)
BBC : 44.07 (+1.68%)
BTEC : 46.36 (+1.56%)
ARKG : 57.63 (+2.64%)
IDN : 8.02 (+1.65%)
VXRT : 8.15 (-8.12%)
GNOM : 18.71 (+1.91%)
5 Top-Performing ETF Areas of April That Are Up At Least 25%

These ETF areas showered gains in the lockdown-infected April.

GILD : 75.61 (-1.06%)
AMLP : 23.70 (+0.17%)
XBI : 116.77 (+1.50%)
SGDM : 33.65 (+3.32%)
AMZA : 16.50 (-0.24%)
FCG : 7.28 (unch)
RING : 32.10 (+3.08%)
IBUY : 77.16 (+2.23%)
MLPA : 25.97 (-0.04%)
GOEX : 34.45 (+2.49%)
BTEC : 46.36 (+1.56%)
AMU : 8.05 (+0.50%)
GOAU : 22.49 (+3.88%)
ON : 19.97 (+3.63%)
5 High-Beta ETFs Available at a Bargain

As the U.S. economy reopens, Wall Street may remain charged up, benefiting high-beta ETFs. Investors can tap those with cheaper valuation.

SPY : 316.18 (+0.76%)
XHB : 45.05 (+2.11%)
XRT : 44.32 (+1.23%)
XTH : 71.14 (-0.18%)
RFV : 49.86 (+0.67%)
SPHB : 39.39 (+1.10%)
BTEC : 46.36 (+1.56%)
A Guide to Biotech ETF Investing

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

SBIO : 42.89 (+1.61%)
BBP : 48.98 (+0.51%)
BTEC : 46.36 (+1.56%)
BBH : 168.10 (+0.48%)
XBI : 116.77 (+1.50%)
IBB : 140.81 (+0.54%)
FBT : 174.53 (+0.90%)
CNCR : 27.76 (+0.54%)
PBE : 60.84 (+1.25%)
ARKG : 57.63 (+2.64%)
Top-Performing Biotech ETFs YTD

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.

RHHBY : 44.1200 (+1.17%)
BMY : 59.56 (-1.21%)
XBI : 116.77 (+1.50%)
BTEC : 46.36 (+1.56%)
BBH : 168.10 (+0.48%)
SBIO : 42.89 (+1.61%)
ILMN : 369.87 (-0.60%)
CELG : 108.24 (+0.10%)
GILD : 75.61 (-1.06%)
GLPG : 200.47 (-0.74%)
AMGN : 251.59 (-0.62%)
EC : 11.42 (+1.33%)
ARKG : 57.63 (+2.64%)
Why These Innovative Biotech ETFs Soaring

Strong M&A activity has sent shares of many small, innovative biotech companies surging

NVTA : 34.24 (+3.07%)
PFE : 33.75 (-0.82%)
MRK : 77.92 (-1.02%)
LLY : 169.13 (+1.43%)
BMY : 59.56 (-1.21%)
BTEC : 46.36 (+1.56%)
SBIO : 42.89 (+1.61%)
ILMN : 369.87 (-0.60%)
ARRY : 47.85 (unch)
CELG : 108.24 (+0.10%)
ARKG : 57.63 (+2.64%)
Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

NVS : 88.12 (+0.36%)
LLY : 169.13 (+1.43%)
RHHBY : 44.1200 (+1.17%)
PFE : 33.75 (-0.82%)
JNJ : 143.27 (+0.29%)
SBIO : 42.89 (+1.61%)
BTEC : 46.36 (+1.56%)
BBP : 48.98 (+0.51%)
XBI : 116.77 (+1.50%)
ONCE : 110.05 (-3.10%)
ILMN : 369.87 (-0.60%)
ARKG : 57.63 (+2.64%)
Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

NVS : 88.12 (+0.36%)
LLY : 169.13 (+1.43%)
RHHBY : 44.1200 (+1.17%)
PFE : 33.75 (-0.82%)
JNJ : 143.27 (+0.29%)
SBIO : 42.89 (+1.61%)
BTEC : 46.36 (+1.56%)
BBP : 48.98 (+0.51%)
XBI : 116.77 (+1.50%)
ONCE : 110.05 (-3.10%)
ILMN : 369.87 (-0.60%)
ARKG : 57.63 (+2.64%)
Health Day Checkup of Medical ETFs: 5 Top Picks

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

LLY : 169.13 (+1.43%)
BMY : 59.56 (-1.21%)
GSK : 40.73 (+0.87%)
VHT : 196.69 (+0.23%)
BTEC : 46.36 (+1.56%)
BBH : 168.10 (+0.48%)
FBT : 174.53 (+0.90%)
IYH : 219.70 (+0.09%)
XBI : 116.77 (+1.50%)
XLV : 101.75 (+0.01%)
CELG : 108.24 (+0.10%)
ONCE : 110.05 (-3.10%)
NITE : 25.41 (-0.04%)
Health Day Checkup of Medical ETFs: 5 Top Picks

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

LLY : 169.13 (+1.43%)
BMY : 59.56 (-1.21%)
GSK : 40.73 (+0.87%)
VHT : 196.69 (+0.23%)
BTEC : 46.36 (+1.56%)
BBH : 168.10 (+0.48%)
FBT : 174.53 (+0.90%)
IYH : 219.70 (+0.09%)
XBI : 116.77 (+1.50%)
XLV : 101.75 (+0.01%)
CELG : 108.24 (+0.10%)
ONCE : 110.05 (-3.10%)
NITE : 25.41 (-0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BTEC with:

Fund Summary

The Principal Healthcare Innovators Index ETF seeks to provide investment results that closely correspond, before expenses, to the performance of the NASDAQ U.S. Healthcare Innovators Index. The ETF employs a passive investment approach designed to track the performance of the Index.

See More

Key Turning Points

2nd Resistance Point 46.42
1st Resistance Point 46.04
Last Price 46.36
1st Support Level 45.23
2nd Support Level 44.81

See More

52-Week High 46.53
Last Price 46.36
Fibonacci 61.8% 38.44
Fibonacci 50% 35.93
Fibonacci 38.2% 33.43
52-Week Low 25.34

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar